antiinflammatory · preclinical
KPV
Tripeptídeo C-terminal de α-MSH.
Status:preclinical
Updated:May 13, 2026
Contributors:2
Half-life
1.5 h
Routes
SC, oral
Typical dose
200–500 mcg
Mechanism of action
Anti-inflamatório, antimicrobial.
Reported applications
- · gut inflammation
- · skin
Frequently asked
What is KPV?
Tripeptídeo C-terminal de α-MSH.
What is the half-life of KPV?
Reference half-life: approximately 1.5 hours. Individual pharmacokinetics may vary.
Is PX7 prescribing KPV?
No. PX7 is an educational reference and a community knowledge layer. It does not prescribe, sell, or recommend substances.
Explore the cluster
PX7 publishes educational and community-curated references on regenerative and longevity science. Nothing on this page is medical advice, prescription, or a recommendation to obtain or use any substance. Always consult a qualified clinician.